Ondine Biomedical Inc Financial Flexibility Index
Ondine Biomedical Inc financial flexibility index. Ondine Biomedical Inc (OBI) has a Financial Flexibility Index of -1.07x as of June 2026. Free cash flow of GBX-13.05 Million (operating CF GBX-13.16 Million minus capex GBX111.64K) represents -1% of total liabilities (GBX12.17 Million). See cash generation quality of Ondine Biomedical Inc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Ondine Biomedical Inc (2001–2025)
Financial flexibility index of Ondine Biomedical Inc from 2001 to 2025. Historical Financial Flexibility Index trend for Ondine Biomedical Inc across 18 annual periods. Explore debt repayment capacity of Ondine Biomedical Inc to assess how comfortably operating cash covers total debt obligations.
Ondine Biomedical Inc Financial Flexibility Index by Year (2001–2025)
Ondine Biomedical Inc financial flexibility index by year from 2001 to 2025. Year-by-year free cash flow to debt coverage for Ondine Biomedical Inc. For the full cash flow conversion analysis, see Ondine Biomedical Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.18x | GBX-23.79 Million | GBX-23.90 Million | GBX10.91 Million | ▲ +16.3% |
| 2024 | -2.60x | GBX-15.48 Million | GBX-15.49 Million | GBX5.95 Million | ▲ +29.5% |
| 2023 | -3.69x | GBX-13.48 Million | GBX-13.65 Million | GBX3.65 Million | ▼ -13.4% |
| 2022 | -3.26x | GBX-16.03 Million | GBX-16.34 Million | GBX4.92 Million | ▼ -17.1% |
| 2021 | -2.78x | GBX-12.46 Million | GBX-12.54 Million | GBX4.48 Million | ▼ -1526.6% |
| 2020 | -0.17x | GBX-6.23 Million | GBX-6.33 Million | GBX36.46 Million | ▲ +34.1% |
| 2019 | -0.26x | GBX-7.52 Million | GBX-7.55 Million | GBX28.99 Million | ▲ +41.6% |
| 2018 | -0.44x | GBX-9.95 Million | GBX-10.08 Million | GBX22.40 Million | ▼ -11.7% |
| 2017 | -0.40x | GBX-4.83 Million | GBX-5.27 Million | GBX12.16 Million | ▲ +64.7% |
| 2010 | -1.13x | GBX-2.54 Million | GBX-2.72 Million | GBX2.25 Million | ▲ +56.0% |
| 2009 | -2.56x | GBX-3.44 Million | GBX-3.44 Million | GBX1.34 Million | ▲ +52.4% |
| 2008 | -5.38x | GBX-8.66 Million | GBX-8.93 Million | GBX1.61 Million | ▼ -1.4% |
| 2007 | -5.31x | GBX-11.46 Million | GBX-11.90 Million | GBX2.16 Million | ▲ +2.4% |
| 2006 | -5.44x | GBX-10.18 Million | GBX-10.84 Million | GBX1.87 Million | ▲ +49.8% |
| 2005 | -10.82x | GBX-8.06 Million | GBX-8.39 Million | GBX745.61K | ▼ -3722.9% |
| 2003 | -0.28x | GBX-66.20K | GBX-66.20K | GBX233.99K | ▼ -261.4% |
| 2002 | 0.18x | GBX25.26K | GBX25.26K | GBX144.13K | ▲ +120.5% |
| 2001 | -0.85x | GBX-49.50K | GBX-49.50K | GBX58.02K | — |